Completed

Evaluation of the Efficacy of an Anti-aging Repairing Serum Containing Hyaluronic Acid, Vitamin B5, Madecassoside and La Roche-Posay Thermal Spring Water

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Topical serum

Other
Who is being recruted

From 45 to 65 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: March 2018
See protocol details

Summary

Principal SponsorCosmetique Active International
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 14, 2018

Actual date on which the first participant was enrolled.

This clinical trial is designed to evaluate a special serum that aims to reduce signs of aging in the skin. The serum contains a combination of ingredients including Hyaluronic Acid, Vitamin B5, Madecassoside, and La Roche-Posay Thermal Spring Water. The study targets individuals who are seeking ways to improve their skin's appearance and combat aging effects. The importance of this study lies in its potential to offer a new and effective skincare solution that could help people maintain youthful-looking skin, addressing a common concern for many. Participants in the trial will apply the serum to specific areas of the skin, such as the forehead, around the eyes, mouth, and neck. Researchers will monitor the changes in skin condition over time by collecting data and analyzing it using statistical methods. This involves looking at different measurements and using graphs to visually assess how the skin condition evolves. The study adheres to strict ethical guidelines to ensure the safety and reliability of the findings, providing a thorough evaluation of the serum's effectiveness.

Official TitleEvaluation of the Efficacy of an Anti-aging Repairing Serum Containing Hyaluronic Acid, Vitamin B5, Madecassoside and La Roche-Posay Thermal Spring Water
NCT06059274
Principal SponsorCosmetique Active International
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

34 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 45 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
phototype I to IV

presenting wrinkles on the forehead and/or peri-orbital area with grade ≥ 2 and ≤4 according to "Skin Aging Atlas"

participant has not used any anti-aging products or performed aesthetic procedures over the last three months

2 exclusion criteria prevent from participating
pregnant, breastfeeding or immune compromised woman

participant with cutaneous marks or active dermatoses on the tested area that could interfere with the evaluation

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
An investigational topical serum containing hyaluronic acid, vitamin B5, madecassoside and La Roche-Posay Thermal Spring Water

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

CIDP Brasil

Rio de Janeiro, BrazilOpen CIDP Brasil in Google Maps
CompletedOne Study Center